Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 3/20 | 0.51 |
| ▸ | NOS1 | P29475 | 3/20 | 0.51 |
| ▸ | NOS2 | P35228 | 3/20 | 0.51 |
| ▸ | TAS1R3 | Q7RTX0 | 7/20 | 0.50 |
| ▸ | TAS1R1 | Q7RTX1 | 7/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4426485 | 1.00 | NOS3 (0.51) | NOS3NOS1NOS2TAS1R3TAS1R1 | |
| SCHEMBL4423941 | 0.91 | ATM (0.48) | LMNAFOLH1ALDH1A1THRB | |
| SCHEMBL4423940 | 0.91 | ATM (0.48) | LMNAFOLH1ALDH1A1THRB | |
| SCHEMBL4433880 | 0.85 | ALDH1A1 (0.47) | LMNAALDH1A1THRB | |
| SCHEMBL6475048 | 0.85 | ALDH1A1 (0.47) | LMNAALDH1A1THRB | |
| SCHEMBL6482103 | 0.83 | ALDH1A1 (0.50) | LMNAALDH1A1THRB | |
| SCHEMBL4421840 | 0.83 | ALDH1A1 (0.50) | LMNAALDH1A1THRB | |
| SCHEMBL8744783 | 0.81 | PPID (0.46) | NOS3NOS1NOS2TAS1R3TAS1R1 | |
| SCHEMBL9594765 | 0.81 | PPID (0.46) | NOS3NOS1NOS2TAS1R3TAS1R1 | |
| SCHEMBL27387008 | 0.81 | NOS3 (0.51) | NOS3NOS1NOS2TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6939888-B2 | 1-H-3-arylpirrolidine-2,4-dione derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 2005-09-06 | — | — | US | disclosed |
| US-20040019061-A1 | 1-H-3-arylpirrolidine-2,4-dione derivatives | FISCHER REINER (DE) | 2004-01-29 | — | — | US | disclosed |
| US-6472419-B1 | 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040019061-A1 | 1-H-3-arylpirrolidine-2,4-dione derivatives | PRXL2A, DDT, CYP4B1 | NOS3 3267/4885NOS1 3560/4885NOS2 3841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.